Just before Thanksgiving, the Centers for Medicare and Medicaid Services (CMS) released its proposed Medicare Advantage (MA) and Medicare Part D (prescription drug) plan rules for calendar year (CY) 2027. Generally, the proposal revises CMS’ star rating system, modifies enrollment rules for individuals whose providers are leaving their current plan, and requests comments on MA program improvements.

CMS is proposing actions in the Medicare Advantage (MA) and Medicare Part D prescription drug programs to continue to strengthen protections and access to care for people with Medicare. The proposed rule aims to hold MA and Part D plans more accountable for delivering high-quality coverage so that people with Medicare are connected to the care they need when they need it.

NAIFA CEO Kevin Mayeux announced that NAIFA will fight decisions to terminate existing marketing service agreements and end new and renewal commissions for Medicare prescription drug (Part D) plans. NAIFA will work with the Centers for Medicare and Medicaid Services (CMS) to make sure the agency (and insurers) knows that these decisions “will curtail personal service.” NAIFA will also “offer solutions to protect” Medicare D beneficiaries., Mayeux said.